{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:07:33Z","timestamp":1791310053977,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005000","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T00:00:00Z","timestamp":1387238400000}}],"reference-count":92,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005000.pub2","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T14:33:28Z","timestamp":1387290808000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Aripiprazole alone or in combination for acute mania"],"prefix":"10.1002","volume":"2013","author":[{"given":"Rachel","family":"Brown","sequence":"first","affiliation":[{"name":"Oxford Health NHS Foundation Trust; Clinical Pharmacy Support Unit; Unit 46, Sandford Lane Kennington Oxford UK OX1 5RW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Taylor","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, King's College London; Department of Psychosis Studies; De Crespigny Park London UK SE5 8AF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"University of Oxford\/Warneford Hospital; Department of Psychiatry; Oxford UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,17]]},"reference":[{"key":"10.1002\/14651858.CD005000.pub2-BIB0001|cit1","unstructured":"Bristol-Myers Squibb Clinical study report synopsis, protocol CN138-007 [data on file]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.euroneuro.2010.07.003","article-title":"A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)","volume":"11","author":"Mallakh","year":"2010","journal-title":"European Neuropsychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD005000.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar I disorder, Manic or mixed episode, with aripiprazole:randomized, double-blind, placebo-controlled study [NCT00110461]","volume":"70","author":"Findling","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD005000.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jad.2012.04.033","article-title":"Respondent and item level patterns of response of aripiprazole in the acute treatment of pediatric bipolar i disorder","volume":"143","author":"Findling","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0005|cit5","first-page":"185","article-title":"Line item analysis in child and adolescent patients with bipolar I disorder treated with Aripiprazole in an acute study (31-03-240) [conference abstract]","volume":"20","author":"Loze","year":"2011","journal-title":"European Child and Adolescent Psychiatry [abstracts from the 14th International Congress of ESCAP European Society for Child and Adolescent Psychiatry]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0006|cit6","first-page":"26","article-title":"Line item analysis in paediatric patients with bipolar I disorder treated with aripiprazole [conference abstract]","author":"Loze","year":"2011","journal-title":"European Psychiatry [abstracts from the 19th European Congress of Psychiatry, EPA 2011 Mar 12-15; Vienna, Austria]"},{"issue":"4","key":"10.1002\/14651858.CD005000.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/cap.2010.0100","article-title":"Young mania rating scale line item analysis in pediatric subjects with bipolar i disorder treated with aripiprazole in a short-term, double-blind, randomized study","volume":"21","author":"Mankoski","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0008|cit8","first-page":"NR4","article-title":"YMRS line item analysis in pediatric patients with bipolar i disorder treated with aripiprazole [conference abstract]","author":"Mankoski","year":"2010","journal-title":"163rd Annual Meeting of the American Psychiatric Association; 2010 May 22-26; New Orleans, LA"},{"issue":"2","key":"10.1002\/14651858.CD005000.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/cap.2012.0024","article-title":"Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder","volume":"23","author":"Youngstrom","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005000.pub2-BIB0010|cit10","first-page":"57","article-title":"Aripiprazole vs placebo in acute mania [abstract]","volume":"5","author":"Jody","year":"2002","journal-title":"International Journal of Neuropsychopharmacology [Proceedings of the 23rd Congress of the Collegium Internationale Neuro-Psychopharmacologicum; 2002 June 23-27; Montreal, Canada]"},{"issue":"9","key":"10.1002\/14651858.CD005000.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0013|cit12","unstructured":"Marcus R Saha A Jody D Tourkodimitris S Archibald D Iwamoto T Aripiprazole versus placebo in acute mania New Research Abstracts, 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA. 2002 p86, Abstract no: NR314"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005000.pub2-BIB0012|cit13","first-page":"S289","article-title":"Aripiprazole versus placebo in acute mania [abstract]","volume":"12","author":"Marcus","year":"2002","journal-title":"European Neuropsychopharmacology [Proceedings of the 15th International Congress of the European College of Neuropsychopharmacology; 2002 October 5-9; Barcelona, Spain]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0014|cit14","unstructured":"Bristol Myers-Squibb Addendum to Clinical Study Report for Study CN138135: A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole monotherapy in the treatment of acutely manic patients with bipolar I disorder Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2008"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0015|cit15","unstructured":"Bristol Myers-Squibb Clinical study report synopsis: A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole monotherapy in the treatment of acutely manic patients with bipolar I disorder [CN138135] Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2008"},{"issue":"3","key":"10.1002\/14651858.CD005000.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2011.11.043","article-title":"A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar i disorder","volume":"136","author":"El-Mallakh","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomised, double-blind, placebo and lithium controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0018|cit18","unstructured":"Bristol Myers Squibb Study to evaluate the efficacy and safety of aripiprazole administered with lithium or valproate over 12 weeks in the treatment of mania in bipolar I disorder http:\/\/clinicaltrials.gov\/show\/NCT00665366 2013"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0019|cit19","unstructured":"Bristol-Myers Squibb Clinical study report synopsis: a multicenter, randomized, double-blind study of aripiprazole versus placebo in the treatment of acutely manic patients with bipolar disorder [CN138074] Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2003"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005000.pub2-BIB0020|cit20","first-page":"39","article-title":"Aripiprazole in acute mania: results from a second placebo-controlled study","volume":"6","author":"Hadjakis WJMarcus","year":"2004","journal-title":"Bipolar Disorders"},{"issue":"4","key":"10.1002\/14651858.CD005000.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3 week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0022|cit22","unstructured":"Sachs GS Sanchez R Marcus RN Kujawa MJ Archibald DG Carson WH Jr Aripiprazole versus placebo in patients with an acute manic or mixed episode New Research Abstracts, 157th Annual Meeting of the American Psychiatric Association; 2004 May 1-6; New York, NY. 2004 p279, Abstract No:NR742"},{"issue":"5","key":"10.1002\/14651858.CD005000.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.08m04726","article-title":"Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder:a pilot randomised clinical trial [NCT00116259]","volume":"70","author":"Tramontina","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0024|cit24","unstructured":"Bourin M Auby P Marcus RN Swanik R McQuade RD Iwamoto T Aripiprazole versus haloperidol for maintained treatment effect in acute mania New Research Abstracts 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco CA. 2003 p175, Abstract No:NR467"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005000.pub2-BIB0025|cit25","first-page":"S333","article-title":"Aripiprazole vs. haloperidol for maintained treatment effect in acute mania","volume":"13","author":"Bourin","year":"2003","journal-title":"European Neuropsychopharmacology [abstracts of the 16th Congress of the European College of Neuropsychopharmacology; 2003 September 20-24; Prague, Czech Republic]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0026|cit26","unstructured":"Bristol Myers-Squibb Clinical study report synopsis: a multicenter, randomized, double-blind study of aripiprazole and haloperidol in the maintained response to treatment for an acute manic episode (Protocol CN138008) Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2003"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0027|cit27","unstructured":"Bristol-Myers Squibb Cumulative 26-Week Clinical Study Report Including the 14-Week Extension Phase CN138008: a multicenter, randomized, double-blind study of aripiprazole and haloperidol in the maintained response to treatment for an acute manic episode Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2003"},{"issue":"Suppl1","key":"10.1002\/14651858.CD005000.pub2-BIB0028|cit28","first-page":"p80, Abstract n","article-title":"Aripiprazole vs. haloperidol for maintained treatment effect in acute mania","volume":"5","author":"Sanchez","year":"2003","journal-title":"Bipolar Disorders [Posters - Fifth International Conference on Bipolar Disorder; 2003 June 12-14; Pittsburgh, PA, USA]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0030|cit30","unstructured":"Bristol-Myers Squibb Addendum 01 to Clinical Study Report for Study CN138134: efficacy of aripiprazole in combination with valproate or lithium in the treatment of mania in patients with bipolar I disorder partially nonresponsive to valproate or lithium monotherapy Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2008"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0031|cit31","unstructured":"Bristol-Myers Squibb Clinical study synopsis report: efficacy of aripiprazole in combination with valproate or lithium in the treatment of mania in patients with bipolar I disorder partially nonresponsive to valproate or lithium monotherapy [CN138134] Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2007"},{"issue":"10","key":"10.1002\/14651858.CD005000.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate or lithium monotherapy: a placebo-controlled study [NCT00257972, CN138-134] [Comment in Am J Psychiatry. 2008 Oct;165(10):1234-6]","volume":"165","author":"VIeta","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0033|cit33","unstructured":"Bristol-Myers Squibb Clinical study synopsis report: a multicenter, randomized, double-blind, placebo-controlled study of aripiprazole monotherapy in the treatment of acutely manic patients with bipolar I disorder [CN138162] Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com] 2007"},{"issue":"1","key":"10.1002\/14651858.CD005000.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12 week randomised placebo- and haloperidol-controlled study [NCT00097266, CN138-162]","volume":"194","author":"Young","year":"2009","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0035|cit35","unstructured":"Bristol Myers Squibb Synpotic Clinical Study Report: a multicentre, randomized, double-blind, placebo-controlled study of aripiprazole in the treatment of acutely manic patients with bipolar disorder [CN138077] Clinical Trials Results Bristol Myers Squibb [http:\/\/ctr.bms.com]"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005000.pub2-BIB0036|cit36","first-page":"186","article-title":"Efficacy of adjunctive aripiprazole to lithium or valproate in the long-term treatment of mania in subjects with bipolar I disorder (CN138-189) [conference abstract]","volume":"26","author":"Abbar","year":"2011","journal-title":"European Psychiatry [abstracts from the 19th European Congress of Psychiatry, EPA 2011 Mar 12-15; Vienna, Austria]"},{"issue":"s1","key":"10.1002\/14651858.CD005000.pub2-BIB0037|cit37","first-page":"27","article-title":"Aripiprazole with lithium or valproate in the long-term treatment of mania in patients with bipolar I disorder (CN138-189) [conference poster P3]","volume":"13","author":"Ammerman","year":"2011","journal-title":"Bipolar Disorders [abstracts of the 9th International Conference on Bipolar Disorder; 9 - 11 June 2011, Pittsburgh, PA United States]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0038|cit38","unstructured":"Bristol Myers Squibb Clinical study report synopsis: efficacy of aripiprazole in combination with lithium or valproate in the long term treatment of mania in patients with bipolar I disorder partially nonresponsive to lithium or valproate monotherapy [CN138189] Clinical Trials Results Bristol Myers Squibb [http:\/\/ctr.bms.com]"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005000.pub2-BIB0039|cit39","first-page":"S431","article-title":"Long-term metabolic effects of aripiprazole adjunctive to lithium, valproate or lamotrigine [conference abstract]","volume":"21","author":"Hert","year":"2011","journal-title":"European Neuropsychopharmacology [abstracts from the 24th Congress of the European College of Neuropsychopharmacology, ECNP 2011 Paris France, 3-7 Sept]"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005000.pub2-BIB0040|cit40","first-page":"S429","article-title":"Effect of aripiprazole adjunctive to lithium or valproate on manic and mixed subpopulations: 52-week, double-blind, randomised relapse prevention trial [conference abstract]","volume":"21","author":"Fountoulakis","year":"2011","journal-title":"European Neuropsychopharmacology [abstracts from the 24th Congress of the European College of Neuropsychopharmacology, ECNP 2011 Paris France, 3-7 Sept]"},{"issue":"2","key":"10.1002\/14651858.CD005000.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1399-5618.2011.00898.x","article-title":"Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study [CN138-189]","volume":"13","author":"Marcus","year":"2011","journal-title":"Bipolar Disorders"},{"issue":"s1","key":"10.1002\/14651858.CD005000.pub2-BIB0042|cit42","first-page":"70","article-title":"Does shorter vs. longer time to stabilization in patients with bipolar i disorder predict relapse prevention? (CN138-189) [conference poster P132]","volume":"13","author":"Masand","year":"2011","journal-title":"Bipolar Disorders [abstracts of the 9th International Conference on Bipolar Disorder; 9 - 11 June 2011, Pittsburgh, PA United States]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0043|cit43","first-page":"NR4","article-title":"Efficacy of adjunctive aripiprazole to lithium or valproate in the long-term treatment of mania in subjects with bipolar i disorder (CN138-189) [conference abstract].","author":"Owen","year":"2010","journal-title":"163rd Annual Meeting of the American Psychiatric Association; 2010 May 22-26; New Orleans, LA"},{"issue":"1-3","key":"10.1002\/14651858.CD005000.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jad.2012.11.042","article-title":"Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar i patients stratified by index manic or mixed episode","volume":"147","author":"Yatham","year":"2013","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0045|cit45","article-title":"A double-blind, randomized, placebo-controlled trial of aripiprazole plus valproate in the short-term and long-term treatment of bipolar disorder","author":"Korea Otsuka International Asia Arab","year":"2012","journal-title":"http:\/\/clinicaltrials.gov\/show\/NCT00484471"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0046|cit46","unstructured":"OtsukaPharmaceutical Co Ltd A multicentre investigative study of the safety and efficacy of long-term administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episode http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00606229 2011"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0047|cit47","unstructured":"Otsuka Pharmaceutical Development & Commercialization Inc Efficacy, safety, and tolerability of an intramuscular formulation of aripiprazole (OPC-14597) as maintenance treatment in bipolar I patients http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01567527"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005000.pub2-BIB0048|cit48","first-page":"S482","article-title":"A randomised, double-blind, placebo-controlled 24 week trial of aripiprazole in recently remitted bipolar I patients [conference abstract, NCT00545675]","volume":"21","author":"Bhak","year":"2011","journal-title":"Neuropsychopharmacology [abstracts from the 24th Congress of the European College of Neuropsychopharmacology, ECNP 2011 Paris France, 3-7 Sept]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0049|cit49","unstructured":"Korea Otsuka Pharmaceutical Co Ltd Multicentre, double-blind, randomized, comparative phase 4 clinical trial to evaluate the efficacy and safety of co-administration of Abilify and Depakote in 24 week treatment of mania in patients with bipolar disorder remitted after 6-week treatment with Abilify and Depakote http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00545675 2010"},{"issue":"8","key":"10.1002\/14651858.CD005000.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/hup.1240","article-title":"Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6 month, randomized, placebo-controlled, double-blind maintenance trial","volume":"26","author":"Woo","year":"2011","journal-title":"Human Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD005000.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/cap.2009.0037","article-title":"Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit\/hyperactivity disorder: a randomised crossover trial","volume":"19","author":"Zeni","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0052|cit52","unstructured":"Bristol Myers Squibb Clinical study report synopsis: a randomised, double-blind comparison of the efficacy and safety of aripiprazole intramuscular formula, lorazepam, or placebo in the treatment of acutely agitated patients diagnosed with bipolar I disorder, manic or mixed [CN138013] Clinical Trials Results Bristol-Myers Squibb [http:\/\/ctr.bms.com]"},{"issue":"2","key":"10.1002\/14651858.CD005000.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0b13e318033bd5e","article-title":"Management of acute agitation in patients with bipolar disorder - efficacy and safety of intramuscular aripiprazole","volume":"27","author":"Zimbroff","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.669047","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study)","volume":"epub ahead of p","author":"Kanba","year":"2012","journal-title":"World Journal of Biological Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005000.pub2-BIB0055|cit55","first-page":"88","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (The AMAZE Study) [poster P116]","volume":"14","author":"Kawasaki","year":"2012","journal-title":"Bipolar Disorders [abstracts of the 5th Biennial Conference of the International Society for Bipolar Disorders. March 14-17, 2012. Istanbul, Turkey]"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0056|cit56","unstructured":"Otsuka Pharmaceutical Co Ltd A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group-Comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode http:\/\/ClinicalTrials.gov\/ct2\/show\/NCT00606281"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0057|cit57","volume-title":"Diagnostic and Statistical Manual of Mental Health Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005000.pub2-BIB0058|cit58","first-page":"4","article-title":"Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005000.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1592\/phco.24.2.212.33145","article-title":"Aripiprazole, a novel atypical antipsychotic drug","volume":"24","author":"Argo","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0060|cit60","unstructured":"Bristol Myers Squibb Clinical trial results BMS.com (www.bms.com\/clinical_trials\/results\/Pages\/default.aspx) (accessed February 2012)"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD005000.pub2-BIB0061|cit61","first-page":"S186","article-title":"Meta-analysis of prolactin effects with aripiprazole","volume":"5","author":"Carson","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Issue 3","key":"10.1002\/14651858.CD005000.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004362.pub2","article-title":"Haloperidol alone or in combination for acute mania","author":"Cipriani","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD005000.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/11584270-000000000-00000","article-title":"Aripiprazole in acute mania and long-term treatment of bipolar disorder","volume":"30","author":"Fazio","year":"2010","journal-title":"Clinical Drug Investigation"},{"issue":"15","key":"10.1002\/14651858.CD005000.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2165\/00019053-200321150-00002","article-title":"Frequency of hospitalisations and inpatient care costs of manic episodes in patients with bipolar I disorder in France","volume":"12","author":"Zelicourt","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD005000.pub2-BIB0066|cit66","first-page":"76","article-title":"Optimizing lithium treatment","volume":"61","author":"Dunner","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.euroneuro.2010.07.003","article-title":"A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)","volume":"11","author":"ElMallakh","year":"2010","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0068|cit68","unstructured":"The European Agency for the Evaluation of Medicinal Products Note for guidance on clinical investigation of medicinal products for the treatment and prevention of bipolar disorder http:\/\/www.emea.eu.int\/pdfs\/human\/ewp\/056798en.pdf"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1744-859X-8-16","article-title":"Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review","volume":"8","author":"Fountoulakis","year":"2009","journal-title":"Annals of General Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2010.10.018","article-title":"Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis","volume":"133","author":"Fountoulakis","year":"2011","journal-title":"Journal of Affective Disorders"},{"issue":"7273","key":"10.1002\/14651858.CD005000.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: a systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD005000.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin GM and the Consensus Group of the British Association for Psychopharmacology","year":"2009","journal-title":"Journal of Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD005000.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","article-title":"Mechanism of new antipsychotic medications","volume":"60","author":"Grunder","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0074|cit74","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume":"[updated March","author":"Higgins","year":"2011"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD005000.pub2-BIB0075|cit75","first-page":"S186","article-title":"Meta-analysis of weight effects with aripiprazole","volume":"5","author":"Jody","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD005000.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at human 5HT1a receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"European Journal of Pharmacology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005000.pub2-BIB0077|cit77","first-page":"3","article-title":"Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications","volume":"63","author":"Keck","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0078|cit78","first-page":"42","article-title":"The nature of bipolar disorder","volume":"61(Suppl 13)","author":"Manji","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD005000.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials","volume":"61","author":"Marder","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD005000.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jad.2011.10.015","article-title":"New treatment guidelines for acute bipolar mania: a critical review","volume":"140","author":"Nivoli","year":"2012","journal-title":"Journal of Affective Disorders"},{"issue":"51","key":"10.1002\/14651858.CD005000.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0924-9338(02)00680-6","article-title":"Manic episodes: the direct cost of a three month period following hospitalisation","volume":"17","author":"Olie","year":"2002","journal-title":"European Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD005000.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"issue":"Issue 1","key":"10.1002\/14651858.CD005000.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004040","article-title":"Olanzapine alone or in combination for acute mania","author":"Rendell","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Issue 1","key":"10.1002\/14651858.CD005000.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004043.pub2","article-title":"Risperidone alone or in combination for acute mania","author":"Rendell","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13651500050518064","article-title":"Pharmacotherapy of mania: a review","volume":"4","author":"Segal","year":"2000","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","article-title":"Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials","volume":"9","author":"Smith","year":"2007","journal-title":"Bipolar Disorders"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD005000.pub2-BIB0087|cit87","first-page":"S186","article-title":"Meta-analysis of cardiac safety wIth aripiprazole","volume":"5","author":"Stock","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005000.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ebmh.11.1.3-a","article-title":"Missing data and the trouble with LOCF","volume":"11","author":"Streiner","year":"2008","journal-title":"Evidence Based Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD005000.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1742-1241.2003.tb11397.x","article-title":"Aripiprazole - a review of its pharmacology and clinical utility","volume":"57","author":"Taylor","year":"2003","journal-title":"International Journal of Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD005000.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/070674370404900208","article-title":"Prevalence and incidence studies of mood disorders: a systematic review of the literature","volume":"49","author":"Waraich","year":"2004","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005000.pub2-BIB0091|cit91","volume-title":"ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organisation","year":"1992"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005000.pub2-BIB0092|cit92","first-page":"10","article-title":"The role of novel antipsychotics in bipolar disorders","volume":"63","author":"Yatham","year":"2002","journal-title":"Journal of Clinical Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005000.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T12:28:05Z","timestamp":1724070485000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005000.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,17]]},"references-count":92,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005000.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,17]]}}}